Cardiac amyloidosis: evolving approach to diagnosis and management

HK Meier-Ewert, V Sanchorawala, JL Berk… - … treatment options in …, 2011 - Springer
… Therefore, dual organ heart/liver transplantation should be considered in patients with
familial transthyretin amyloidosis complicated by infiltrative cardiomyopathy [50]. The advent of …

Cardiac transthyretin amyloidosis

JN Dungu, LJ Anderson, CJ Whelan, PN Hawkins - Heart, 2012 - heart.bmj.com
… We review here the clinical features of cardiac ATTR amyloidosis and describe the diagnostic
tests to determine ATTR type. Correct diagnosis is ever more crucial given that several …

Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal

Y Ando, M Waddington-Cruz, Y Sekijima… - Orphanet Journal of …, 2023 - Springer
Hereditary transthyretin (ATTRv) amyloidosis is a rare and autosomal dominant disorder
associated with mutations in the transthyretin gene. Patients present with diverse symptoms …

Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis

L Obici, OB Suhr - Clinical Autonomic Research, 2019 - Springer
… To review the management of gastrointestinal symptoms in patients with hereditary transthyretin
amyloidosis, discussing diagnostic evaluations, assessment of disease progression and …

Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts

C Karam, ML Mauermann, A Gonzalez‐Duarte… - Muscle & …, 2024 - Wiley Online Library
… A key part of disease management for patients diagnosed with ATTRv amyloidosis includes
symptomatic treatments, which can reduce symptom burden but do not affect the underlying …

[HTML][HTML] Cardiac amyloidosis: epidemiology, diagnosis and therapy

G Papingiotis, L Basmpana, D Farmakis - EJ Cardiol Pract, 2021 - escardio.org
… Among the different types of amyloidosis, nearly all cases of clinical cardiac amyloidosis (>95%)
are caused by light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) [3,4]. …

Systemic amyloidosis from A (AA) to T (ATTR): a review

E Muchtar, A Dispenzieri, H Magen… - Journal of internal …, 2021 - Wiley Online Library
… resulting in diagnostic delay. The field of amyloidosis has seen significant improvements
over the past decade in diagnostic accuracy, prognosis prediction and management. The …

Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options

H Alkhawam, D Patel, J Nguyen, SM Easaw… - Acta …, 2017 - Taylor & Francis
… There are not many differences in the therapy of heart failure due to light-chain amyloid (AL)
and that of transthyretin amyloidosis (TTR). Diuretics form the mainstay of treatment in …

Inotersen treatment for patients with hereditary transthyretin amyloidosis

MD Benson, M Waddington-Cruz, JL Berk… - … England Journal of …, 2018 - Mass Medical Soc
diagnosis of stage 1 (patient is ambulatory) or stage 2 (patient is ambulatory with assistance)
hereditary transthyretin amyloidosis … besides hereditary transthyretin amyloidosis, previous …

Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment

OK Siddiqi, FL Ruberg - Trends in cardiovascular medicine, 2018 - Elsevier
… to describe clinical features, diagnostic tools, and … a diagnostic algorithm for identification
of cardiac amyloidosis. While treatment has historically focused on symptomatic management